Sexual Dysfunction in Men and Women with Diabetes: A Reflection of their Complications?

Current Diabetes Reviews - Tập 18 Số 1 - 2022
Andrea Sansone1, Daniele Mollaioli1, Giacomo Ciocca1, Erika Limoncin1, Elena Colonnello1, Emmanuele A. Jannini1
1Chair of Endocrinology and Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy

Tóm tắt

Background.: Diabetes mellitus (DM), one of the worldwide leading causes of death, is associated with a plethora of micro- and macro-vascular complications which should be carefully investigated and, in case, treated in order to improve quality of life and reduce the risk of premature mortality. Objective: The study aimed to investigate and report current evidence with regard to the association between sexual dysfunction and diabetes. Methods: A detailed analysis of current literature has been performed on PubMed and Scholar in order to retrieve the most relevant findings pertaining to the study topic. Results: Female and male sexual dysfunction often occurs in diabetes; while cardiovascular complications are clearly involved, psychosexological factors, endocrine complications, and endothelial dysfunction all contribute to the pathogenesis of sexual dysfunctions. Psychological symptoms are seldom investigated, yet they should not be overlooked by the clinician; in fact, an interplay between sexual dysfunctions and depressive symptoms has been reported, and beneficial effects in both conditions might be obtained by adequate psychological support. Sexual dysfunctions can also act as early biomarkers of cardiovascular disease, a phenomenon frequently reported in men, in which erectile dysfunction predicts the development of coronary artery disease. Additionally, drug therapies can act in both directions, with treatments for diabetes possibly improving male sexual function and exerting beneficial effects for cardiovascular health being reported for pro-erectile drugs. Conclusion: Sexual dysfunctions often occur in men and women with diabetes. Investigating micro- and macro-vascular complications might not be enough to prevent the development or worsening of any sexual dysfunction; endocrine and psychological assessments are therefore needed to provide the best chances for adequate treatment.

Từ khóa


Tài liệu tham khảo

Global Report on Diabetes 2016

Filardi T.; Ghinassi B.; Di Baldassarre A.; Tanzilli G.; Morano S.; Lenzi A.; Basili S.; Crescioli C.; Cardiomyopathy associated with diabetes: the central role of the cardiomyocyte. Int J Mol Sci 2019,20(13),E3299

Shamloul R.; Ghanem H.; Erectile dysfunction. Lancet 2013,381(9861),153-165

Kouidrat Y.; Pizzol D.; Cosco T.; Thompson T.; Carnaghi M.; Bertoldo A.; Solmi M.; Stubbs B.; Veronese N.; High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med 2017,34(9),1185-1192

Pontiroli A.E.; Cortelazzi D.; Morabito A.; Female sexual dysfunction and diabetes: a systematic review and meta-analysis. J Sex Med 2013,10(4),1044-1051

Cho N.H.; Shaw J.E.; Karuranga S.; Huang Y.; da Rocha Fernandes J.D.; Ohlrogge A.W.; Malanda B.; IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018,138,271-281

Montorsi P.; Ravagnani P.M.; Galli S.; Rotatori F.; Briganti A.; Salonia A.; Rigatti P.; Montorsi F.; The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 2005,96(12B),19M-23M

Meller S.M.; Stilp E.; Walker C.N.; Mena-Hurtado C.; The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy. J Invasive Cardiol 2013,25(6),313-319

Sims E.A.; Danforth E.; Horton E.S.; Bray G.A.; Glennon J.A.; Salans L.B.; Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 1973,29,457-496

Kahn S.E.; Hull R.L.; Utzschneider K.M.; Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006,444(7121),840-846

Corona G.; Rastrelli G.; Monami M.; Saad F.; Luconi M.; Lucchese M.; Facchiano E.; Sforza A.; Forti G.; Mannucci E.; Maggi M.; Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol 2013,168(6),829-843

Allen M.S.; Walter E.E.; Health-related lifestyle factors and sexual dysfunction: a meta-analysis of population-based research. J Sex Med 2018,15(4),458-475

Corona G.; Isidori A.M.; Aversa A.; Burnett A.L.; Maggi M.; Endocrinologic control of men’s sexual desire and arousal/erection. J Sex Med 2016,13(3),317-337

Sansone A.; Romanelli F.; Gianfrilli D.; Lenzi A.; Endocrine evaluation of erectile dysfunction. Endocrine 2014,46(3),423-430

Corona G.; Goulis D.G.; Huhtaniemi I.; Zitzmann M.; Toppari J.; Forti G.; Vanderschueren D.; Wu F.C.; European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology. Andrology 2020,8(5),970-987

Grossmann M.; Hypogonadism and male obesity: Focus on unresolved questions. Clin Endocrinol 2018,89(1),11-21

Haider K.S.; Haider A.; Saad F.; Doros G.; Hanefeld M.; Dhindsa S.; Dandona P.; Traish A.; Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study. Diabetes Obes Metab 2020,22(11),2055-2068

Miner M.; Esposito K.; Guay A.; Montorsi P.; Goldstein I.; Cardiometabolic risk and female sexual health: the Princeton III summary. J Sex Med 2012,9(3),641-651

Carosa E.; Sansone A.; Jannini E.A.; Management of endocrine disease: Female sexual dysfunction for the endocrinologist. Eur J Endocrinol 2020,182(6),R101

Rahmanian E.; Salari N.; Mohammadi M.; Jalali R.; Evaluation of sexual dysfunction and female sexual dysfunction indicators in women with type 2 diabetes: a systematic review and meta-analysis. Diabetol Metab Syndr 2019,11,73

Giraldi A.; Kristensen E.; Sexual dysfunction in women with diabetes mellitus. J Sex Res 2010,47(2),199-211

Traish A.M.; Botchevar E.; Kim N.N.; Biochemical factors modulating female genital sexual arousal physiology. J Sex Med 2010,7(9),2925-2946

Maseroli E.; Fanni E.; Cipriani S.; Scavello I.; Pampaloni F.; Battaglia C.; Fambrini M.; Mannucci E.; Jannini E.A.; Maggi M.; Vignozzi L.; Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance. J Sex Med 2016,13(11),1651-1661

Coppola A.; Gallotti P.; Choussos D.; Pujia A.; Montalcini T.; Gazzaruso C.; Association between clitoral tissue perfusion and female sexual dysfunction in healthy women of reproductive age: a pilot study. Int J Impot Res 2020,32(2),221-225

Mollaioli D.; Ciocca G.; Limoncin E.; Di Sante S.; Gravina G.L.; Carosa E.; Lenzi A.; Jannini E.A.F.; Lifestyles and sexuality in men and women: the gender perspective in sexual medicine. Reprod Biol Endocrinol 2020,18(1),10

Kolotkin R.L.; Crosby R.D.; Gress R.E.; Hunt S.C.; Engel S.G.; Adams T.D.; Health and health-related quality of life: differences between men and women who seek gastric bypass surgery. Surg Obes Relat Dis 2008,4(5),651-658

Kolotkin R.L.; Binks M.; Crosby R.D.; Østbye T.; Gress R.E.; Adams T.D.; Obesity and sexual quality of life. Obesity 2006,14(3),472-479

Guay A.T.; ED2: erectile dysfunction = endothelial dysfunction. Endocrinol Metab Clin North Am 2007,36(2),453-463

Corona G.; Forti G.; Maggi M.; Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome. Aging Male 2008,11(4),193-199

Jannini E.A.S.M.; SM = SM: The interface of systems medicine and sexual medicine for facing non-communicable diseases in a gender-dependent manner. Sex Med Rev 2017,5(3),349-364

Romanelli F.; Sansone A.; Lenzi A.; Erectile dysfunction in aging male. Acta Biomed 2010,81(Suppl. 1),89-94

Isidori A.M.; Buvat J.; Corona G.; Goldstein I.; Jannini E.A.; Lenzi A.; Porst H.; Salonia A.; Traish A.M.; Maggi M.; A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol 2014,65(1),99-112

Corona G.; Sansone A.; Pallotti F.; Ferlin A.; Pivonello R.; Isidori A.M.; Maggi M.; Jannini E.A.; People smoke for nicotine, but lose sexual and reproductive health for tar: a narrative review on the effect of cigarette smoking on male sexuality and reproduction. J Endocrinol Invest 2020,43(10),1391-1408

Esposito K.; Giugliano D.; The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004,14(5),228-232

Maiorino M.I.; Bellastella G.; Giugliano D.; Esposito K.; From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Invest 2018,41(11),1249-1258

Mohamad N.V.; Wong S.K.; Wan Hasan W.N.; Jolly J.J.; Nur-Farhana M.F.; Ima-Nirwana S.; Chin K.Y.; The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male 2019,22(2),129-140

Sansone A.; Mollaioli D.; Ciocca G.; Addressing male sexual and reproductive health in the wake of COVID-19 outbreak. J Endocrinol Invest Published online 2020 Jul 13.2021,44(2),223-231

Fedele D.; Coscelli C.; Santeusanio F.; Bortolotti A.; Chatenoud L.; Colli E.; Landoni M.; Parazzini F.; Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care 1998,21(11),1973-1977

Boeri L.; Capogrosso P.; Pederzoli F.; Ventimiglia E.; Frego N.; Chierigo F.; Montanari E.; Montorsi F.; Salonia A.; Unrecognized prediabetes is highly prevalent in men with erectile dysfunction-results from a cross-sectional study. J Sex Med 2018,15(8),1117-1124

Lue T.F.; Brant W.O.; Shindel A.; Bella A.J.; Endotext South Dartmouth (MA): MDTextcom, Inc 2017

Same R.V.; Miner M.M.; Blaha M.J.; Feldman D.I.; Billups K.L.; Erectile dysfunction: an early sign of cardiovascular disease. Curr Cardiovasc Risk Rep 2015,9,49

Morano S.; Gatti A.; Mandosi E.; Tiberti C.; Fallarino M.; Cipriani R.; Buchetti B.; Gandini L.; Sgrò P.; Jannini E.A.; Lenti L.; Lenzi A.; Circulating monocyte oxidative activity is increased in patients with type 2 diabetes and erectile dysfunction. J Urol 2007,177(2),655-659

Morano S.; Mandosi E.; Fallarino M.; Gatti A.; Tiberti C.; Sensi M.; Gandini L.; Buchetti B.; Lenti L.; Jannini E.A.; Lenzi A.; Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. Eur Urol 2007,52(6),1768-1774

Adeva-Andany M.M.; Funcasta-Calderón R.; Fernández-Fernández C.; Ameneiros-Rodríguez E.; Domínguez-Montero A.; Subclinical vascular disease in patients with diabetes is associated with insulin resistance. Diabetes Metab Syndr 2019,13(3),2198-2206

Raggi P.; Screening for atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus: controversies and guidelines. Can J Diabetes 2020,44(1),86-92

Corona G.; Jannini E.A.; Maggi M.; Inventories for male and female sexual dysfunctions. Int J Impot Res 2006,18(3),236-250

Maseroli E.; Scavello I.; Vignozzi L.; Cardiometabolic risk and female sexuality-part i. risk factors and potential pathophysiological underpinnings for female vasculogenic sexual dysfunction syndromes. Sex Med Rev 2018,6(4),508-524

Maseroli E.; Scavello I.; Vignozzi L.; Cardiometabolic risk and female sexuality-part II. understanding (and overcoming) gender differences: the key role of an adequate methodological approach. Sex Med Rev 2018,6(4),525-534

Sansone A.; Aversa A.; Corona G.; Fisher A.D.; Isidori A.M.; La Vignera S.; Limoncin E.; Maggi M.; Merico M.; Jannini E.A.; Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine (SIAMS). J Endocrinol Invest Epub 2020 Oct 30.2021 May,44(5),1103-1118

Jannini E.A.; Lombardo F.; Lenzi A.; Correlation between ejaculatory and erectile dysfunction. Int J Androl 2005,28(Suppl. 2),40-45

El-Sakka A.I.; Premature ejaculation in non-insulin-dependent diabetic patients. Int J Androl 2003,26(6),329-334

Corona G.; Giorda C.B.; Cucinotta D.; Guida P.; Nada E.; The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients. J Endocrinol Invest SUBITO-DE study group2013,36(10),864-868

Bellastella G.; Maiorino M.I.; Olita L.; Della Volpe E.; Giugliano D.; Esposito K.; Premature ejaculation is associated with glycemic control in Type 1 diabetes. J Sex Med 2015,12(1),93-99

Corona G.; Giorda C.B.; Cucinotta D.; Guida P.; Nada E.; Sexual dysfunction at the onset of type 2 diabetes: the interplay of depression, hormonal and cardiovascular factors. J Sex Med Gruppo di studio SUBITO-DE2014,11(8),2065-2073

Maiorino M.I.; Bellastella G.; Della Volpe E.; Casciano O.; Scappaticcio L.; Cirillo P.; Giugliano D.; Esposito K.; Erectile dysfunction in young men with type 1 diabetes. Int J Impot Res 2017,29(1),17-22

Goldstein I.; Chambers R.; Tang W.; Stecher V.; Hassan T.; Realworld observational results from a database of 48 million men in the United States: Relationship of cardiovascular disease, diabetes mellitus and depression with age and erectile dysfunction. Int J Clin Pract 2018,72(4),e13078

Albasheer O.B.; Mahfouz M.S.; Solan Y.; Khan D.A.; Muqri M.A.; Almutairi H.A.; Alelyani A.M.; Alahmed H.A.; Depression and related risk factors among patients with type 2 diabetes mellitus, Jazan area, KSA: A cross-sectional study. Diabetes Metab Syndr 2018,12(2),117-121

Avasthi A.; Grover S.; Bhansali A.; Dash R.J.; Gupta N.; Sharan P.; Sharma S.; Erectile dysfunction in diabetes mellitus contributes to poor quality of life. Int Rev Psychiatry 2011,23(1),93-99

De Berardis G.; Franciosi M.; Belfiglio M.; Di Nardo B.; Greenfield S.; Kaplan S.H.; Pellegrini F.; Sacco M.; Tognoni G.; Valentini M.; Nicolucci A.; Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care Quality of Care and Outcomes in Type 2 Diabetes (QuED) Study Group2002,25(2),284-291

Ciocca G.; Carosa E.; Stornelli M.; Limoncin E.; Gravina G.L.; Iannarelli R.; Sperandio A.; Di Sante S.; Lenzi A.; Lauro D.; Jannini E.A.; Post-traumatic stress disorder, coping strategies and type 2 diabetes: psychometric assessment after L’Aquila earthquake. Acta Diabetol 2015,52(3),513-521

Franciosi M.; Pellegrini F.; De Berardis G.; Belfiglio M.; Cavaliere D.; Di Nardo B.; Greenfield S.; Kaplan S.H.; Sacco M.; Tognoni G.; Valentini M.; Nicolucci A.; The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care QuED Study Group2001,24(11),1870-1877

Enzlin P.; Mathieu C.; Van Den Bruel A.; Vanderschueren D.; Demyttenaere K.; Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care 2003,26(2),409-414

Bultrini A.; Carosa E.; Colpi E.M.; Poccia G.; Iannarelli R.; Lembo D.; Lenzi A.; Jannini E.A.; Possible correlation between type 1 diabetes mellitus and female sexual dysfunction: case report and literature review. J Sex Med 2004,1(3),337-340

Maiorino M.I.; Bellastella G.; Castaldo F.; Petrizzo M.; Giugliano D.; Esposito K.; Sexual function in young women with type 1 diabetes: the METRO study. J Endocrinol Invest 2017,40(2),169-177

Yenice M.G.; Danacıoğlu Y.O.; Mert M.; Karakaya P.; Seker K.G.; Akkaş F.; Şimşek A.; Şahin S.; Taşçı A.I.; Evaluation of factors affecting sexual dysfunction in female patients with diabetes mellitus. Arch Endocrinol Metab 2020,64(3),319-325

Nowosielski K.; Skrzypulec-Plinta V.; Mediators of sexual functions in women with diabetes. J Sex Med 2011,8(9),2532-2545

Bąk E.; Marcisz C.; Krzemińska S.; Dobrzyn-Matusiak D.; Foltyn A.; Drosdzol-Cop A.; Relationships of sexual dysfunction with depression and acceptance of illness in women and men with type 2 diabetes mellitus. Int J Environ Res Public Health [Internet].2017,14(9),E1073

Sansone A.; Sansone M.; Lenzi A.; Romanelli F.; Testosterone replacement therapy: the emperor’s new clothes. Rejuvenation Res 2017,20(1),9-14

Corona G.; Rastrelli G.; Reisman Y.; Sforza A.; Maggi M.; The safety of available treatments of male hypogonadism in organic and functional hypogonadism. Expert Opin Drug Saf 2018,17(3),277-292

Dolci S.; Belmonte A.; Santone R.; Giorgi M.; Pellegrini M.; Carosa E.; Piccione E.; Lenzi A.; Jannini E.A.; Subcellular localization and regulation of type-1C and type-5 phosphodiesterases. Biochem Biophys Res Commun 2006,341(3),837-846

Prasad S.; Wilkinson J.; Gatzoulis M.A.; Sildenafil in primary pulmonary hypertension. N Engl J Med 2000,343(18),1342

Yang H-M.; Jin S.; Jang H.; Kim J-Y.; Lee J-E.; Kim J.; Kim H.S.; Sildenafil reduces neointimal hyperplasia after angioplasty and inhibits platelet aggregation via activation of cgmp-dependent protein kinase. Sci Rep 2019,9(1),7769

Giannattasio S.; Corinaldesi C.; Colletti M.; Di Luigi L.; Antinozzi C.; Filardi T.; Scolletta S.; Basili S.; Lenzi A.; Morano S.; Crescioli C.; The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence. J Endocrinol Invest 2019,42(6),715-725

Anderson S.G.; Hutchings D.C.; Woodward M.; Rahimi K.; Rutter M.K.; Kirby M.; Hackett G.; Trafford A.W.; Heald A.H.; Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality. Heart 2016,102(21),1750-1756

Saisho Y.; Metformin and inflammation: its potential beyond glucose-lowering effect. Endocr Metab Immune Disord Drug Targets 2015,15(3),196-205

Pastor-Villaescusa B.; Cañete M.D.; Caballero-Villarraso J.; Hoyos R.; Latorre M.; Vázquez-Cobela R.; Plaza-Díaz J.; Maldonado J.; Bueno G.; Leis R.; Gil Á.; Cañete R.; Aguilera C.M.; Metformin for obesity in prepubertal and pubertal children: a randomized controlled trial. Pediatrics 2017,140(1),e20164285

Jing Y.; Wu F.; Li D.; Yang L.; Li Q.; Li R.; Metformin improves obesity-associated inflammation by altering macrophages polarization. Mol Cell Endocrinol 2018,461,256-264

Goldberg R.B.; Aroda V.R.; Bluemke D.A.; Barrett-Connor E.; Budoff M.; Crandall J.P.; Dabelea D.; Horton E.S.; Mather K.J.; Orchard T.J.; Schade D.; Watson K.; Temprosa M.; Effect of long-term metformin and lifestyle in the diabetes prevention program and its outcome study on coronary artery calcium. Circulation Diabetes prevention program research group2017,136(1),52-64

Giagulli V.A.; Carbone M.D.; Ramunni M.I.; Licchelli B.; De Pergola G.; Sabbà C.; Guastamacchia E.; Triggiani V.; Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism. Andrology 2015,3(6),1094-1103

Matsubara J.; Sugiyama S.; Sugamura K.; Nakamura T.; Fujiwara Y.; Akiyama E.; Kurokawa H.; Nozaki T.; Ohba K.; Konishi M.; Maeda H.; Izumiya Y.; Kaikita K.; Sumida H.; Jinnouchi H.; Matsui K.; Kim-Mitsuyama S.; Takeya M.; Ogawa H.; A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice. J Am Coll Cardiol 2012,59(3),265-276

Assaly R.; Gorny D.; Compagnie S.; Mayoux E.; Bernabe J.; Alexandre L.; Giuliano F.; Behr-Roussel D.; The favorable effect of empagliflozin on erectile function in an experimental model of type 2 diabetes. J Sex Med 2018,15(9),1224-1234

Corona G.; Fagioli G.; Mannucci E.; Romeo A.; Rossi M.; Lotti F.; Sforza A.; Morittu S.; Chiarini V.; Casella G.; Di Pasquale G.; Bandini E.; Forti G.; Maggi M.; Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity measured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease. J Sex Med 2008,5(11),2623-2634

Shao N.; Yu X-Y.; Yu Y-M.; Li B-W.; Pan J.; Wu W-H.; Zhang H.J.; Ma X.F.; Hao M.; Kuang H.Y.; Short-term combined treatment with exenatide and metformin is superior to glimepiride combined metformin in improvement of serum testosterone levels in type 2 diabetic patients with obesity. Andrologia 2018,50(7),e13039

Wing R.R.; Bond D.S.; Gendrano I.N.; Wadden T.; Bahnson J.; Lewis C.E.; Brancati F.; Schneider S.; Kitabchi A.E.; Van Dorsten B.; Rosen R.C.; Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study. Diabetes Care Sexual Dysfunction Subgroup of the Look AHEAD Research Group2013,36(10),2937-2944

Shah M.; Vella A.; Effects of GLP-1 on appetite and weight. Rev Endocr Metab Disord 2014,15(3),181-187